Skip to main content
SpringerLink
Log in

Effect of long term treatment with atypical neuroleptic drugs on beta adrenoceptor binding in rat cerebral cortex and myocardium

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

Several neuroleptic drugs enhance the release and the turnover of noradrenaline in the central nervous system and in peripheral organs. The present study demonstrates the effect of long term treatment (18 days) with atypical neuroleptic drugs (clozapine, thioridazine, and sulpiride) on β-adrenoceptor density in the cerebral cortex and in the myocardium of rats.

  1. 1.

    Clozapine and thioridazine significantly reduced the number of 3H-dihydroalprenolol (DHA)-binding sites by 24 and 21%, respectively, in a crude cortical membrane fraction, and by 28 and 24% in myocardial membranes.

  2. 2.

    Sulpiride failed to alter the maximal number of binding sites in the cortex and in the myocardium.

  3. 3.

    The affinity of 3H-DHA to its binding sites remained unchanged by treatment with neuroleptic drugs.

  4. 4.

    Desipramine, which is known to reduce cerebral β-adrenoceptors during chronic administration, was tested as reference compound. It proved to be more effective in this regard than clozapine and thioridazine in the cortex, but failed to reduce 3H-DHA binding in the myocardium.

  5. 5.

    Acute treatment with desipramine, clozapine, and thioridazine had no effect on 3H-DHA binding in the cerebral cortex.

The decrease in β-adrenoceptor density after long term treatment with neuroleptics may be ascribed to an increased concentration of noradrenaline at the receptor site due to antagonism at presynaptic α2-adrenoceptors and inhibition of noradrenaline reuptake.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ackenheil M (1980) Biochemical effects (in men) In: Hoffmeister F, Stille G (eds) Psychotropic agents, Part I, Handbook of exp. pharmacol. Springer, Berlin Heidelberg New York, pp 213–223

    Google Scholar 

  • Andén N-E, Butcher SG, Corrodi H, Fuxe K, Ungerstedt U (1970) Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 11:303–314

    Google Scholar 

  • Arbilla S, Briley MS, Dubocovich ML, Langer SZ (1978) Neuroleptic binding and their effects on the spontaneous and potassium-evoked release of 3H-dopamine from the striatum and of 3H-noradrenaline from the cerebral cortex. Life Sci 23:1775–1780

    Google Scholar 

  • Banerjee SP, Kung LS, Riggi SJ, Chanda SK (1977) Development of beta-adrenergic receptor subsensitivity by antidepressants. Nature 268:455–456

    Google Scholar 

  • Bartholini G, Keller HH, Pletscher A (1973) Effect of neuroleptics on endogenous norepinephrine in rat brain. Neuropharmacology 12:751–756

    Google Scholar 

  • Bergstrom DA, Kellar KJ (1979) Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment. J Pharmacol Exp Ther 209:256–261

    Google Scholar 

  • Borowski E, Starke K, Ehrl H, Endo T (1977) A comparison of pre- and postsynaptic effects of α-adrenolytic drugs in the pulmonal artery of the rabbit. Neuroscience 2:285–296

    Google Scholar 

  • Bürki HR, Ruch W, Asper H (1975) Effect of clozapine, thioridazine, perlapine and haloperidol on the metabolism of biogenic amines in the brain of the rat. Psychopharmacology 41:27–33

    Google Scholar 

  • Bylund DB, Snyder SH (1976) Beta adrenergic receptor binding in membrane preparations from mammalian brain. Mol Pharmacol 12:568–580

    Google Scholar 

  • Carlsson A, Lindqvist M (1963) Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol 20:140–144

    Google Scholar 

  • Carlsson A, Fuxe K, Hamberger B, Lindqvist M (1966) Biochemical and histochemical studies on the effects of imipramine-like drugs and (+) amphetamine on central and peripheral catecholamine neurons. Acta Physiol Scand 67:481–497

    Google Scholar 

  • Fuder H, Muscholl E (1978) The effect of dopamine on the overflow of endogenous noradrenaline from the perfused rabbit heart evoked by sympathetic nerve stimulation. Naunyn-Schmiedeberg's Arch Pharmacol 305:109–115

    Google Scholar 

  • Galzin AM, Dubocovich ML, Langer SZ (1982) Presynaptic inhibition by dopamine receptor agonists of noradrenergic neurotransmission in the rabbit hypothalamus. J Pharmacol Exp Ther 221:461–471

    Google Scholar 

  • Garattini S, Morselli PL (1978) Metabolism and pharmacokinetics of psychotropic drugs. In: Clark WG, Del Guidice J (eds) Principles of psychopharmacology. Academic Press, New York, pp 169–182

    Google Scholar 

  • Groß G (1980) Presynaptic α-adrenolytic action of neuroleptic drugs on central and peripheral noradrenergic neurons. Naunyn-Schmiedeberg's Arch Pharmacol Suppl 313:R87

    Google Scholar 

  • Groß G, Schümann HJ (1980) Enhancement of noradrenaline release from rat cerebral cortex by neuroleptic drugs. Naunyn-Schmiedeberg's Arch Pharmacol 315:103–109

    Google Scholar 

  • Hrdina PD, Dubas TC (1981) Brain distribution and kinetics of desipramine in the rat. Can J Physiol Pharmacol 59:163–167

    Google Scholar 

  • Langer SZ (1981) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32:337–362

    Google Scholar 

  • LeFur G, Burgevin M-C, Halgouris C, Uzan A (1979) Differential effects of typical and atypical neuroleptics on alpha noradrenergic and dopaminergic postsynaptic receptors. Neuropharmacol 18:591–594

    Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275

    Google Scholar 

  • McMillen BA, Shore PA (1978) Comparative effect of clozapine and α-adrenoceptor blocking drugs on regional noradrenaline metabolism in rat brain. Eur J Pharmacol 52:225–230

    Google Scholar 

  • Mickey JV, Tate R, Mullikin D, Lefkowitz RJ (1976) Regulation of adenylate-cyclase coupled beta-adrenergic receptor binding sites by beta-adrenergic catecholamines in vitro. Mol Pharmacol 12:409–419

    Google Scholar 

  • Miller RJ, Horn AS, Iversen LL (1974) The action of neuroleptic drugs on dopamine-stimulated adenosine cyclic 3′,5′-monophosphate production in rat neostriatum and limbic forebrain. Mol Pharmacol 10:759–766

    Google Scholar 

  • Minneman KP, Hegstrand LR, Molinoff P (1979) Simultaneous determination of beta 1 and beta 2 adrenergic receptors in tissues containing both receptor subtypes. Mol Pharmacol 16:34–46

    Google Scholar 

  • Minneman KP, Pittman RN, Molinoff PB (1981) β-Adrenergic receptor subtypes: properties, distribution, and regulation. Ann Rev Neurosci 4:419–461

    Google Scholar 

  • Peroutka SJ, U'Prichard DC, Greenberg DA, Snyder SH (1977) Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain. Neuropharmacology 16:549–556

    Google Scholar 

  • Raisman R, Briley M, Langer SZ (1980) Specific tricyclic antidepressant binding sites in rat brain characterized by high-affinity 3H-imipramine binding. Eur J Pharmacol 61:373–380

    Google Scholar 

  • Robertson MM, Trimble MR (1981) Neuroleptics as antidepressants. Neuropharmacol 20:1335–1336

    Google Scholar 

  • Ross SB, Renyi AL (1967) Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents. Eur J Pharmacol 2:181–186

    Google Scholar 

  • Sarai K (1978) Desmethylimipramine-induced decrease in β-adrenergic receptor binding in rat cerebral cortex. Biochem Pharmacol 27:2179–2181

    Google Scholar 

  • Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:660–672

    Google Scholar 

  • Schweitzer JW, Schwartz R, Friedhoff AJ (1979) Intact presynaptic terminals required for beta-adrenergic receptor regulation by desipramine. J Neurochem 33:377–379

    Google Scholar 

  • Sellinger-Barnette MM, Mendels J, Frazer A (1980) The effect of psychoactive drugs on beta-adrenergic receptor binding sites in rat brain. Neuropharmacology 19:447–454

    Google Scholar 

  • Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1–124

    Google Scholar 

  • V. Stralendorff B, Ackenheil M, Zimmermann J (1976) Akute und chronische Wirkung von Carpipramin, Clozapin, Haloperidol und Sulpirid auf den Stoffwechsel biogener Amine im Rattengehirn. Drug Res 26:1096–1098

    Google Scholar 

  • Sulser F, Vetulani F, Mobley P (1978) Mode of action of antidepressant drugs. Neuropharmacology 27:257–261

    Google Scholar 

  • Vetulani J, Stawarz RJ, Dingell JV, Sulser F (1976) A possible common mechanism of action of antidepressant treatments. Reduction in the sensitivity of the noradrenergic cyclic AMP generating system. Naunyn-Schmiedeberg's Arch Pharmacol 293:109–114

    Google Scholar 

  • Wiech NL, Ursillo RC (1980) Acceleration of desipramine-induced decrease of rat corticocerebral β-adrenergic receptors by yohimbine. Commun Psychopharmacol 4:95–100

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmakologisches Institut der Universität Essen, Hufelandstrasse 55, D-4300, Essen 1, Federal Republic of Germany

    Gerhard Groß & Hans-Joachim Schümann

Authors
  1. Gerhard Groß
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans-Joachim Schümann
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This study was supported by the Deutsche Forschungsgemeinschaft

Rights and permissions

Reprints and permissions

About this article

Cite this article

Groß, G., Schümann, HJ. Effect of long term treatment with atypical neuroleptic drugs on beta adrenoceptor binding in rat cerebral cortex and myocardium. Naunyn-Schmiedeberg's Arch. Pharmacol. 321, 271–275 (1982). https://doi.org/10.1007/BF00498512

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00498512

Key words

Search

Navigation